Product Images Clobazam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 13 images provide visual information about the product associated with Clobazam NDC 51672-4210 by Taro Pharmaceuticals U.s.a., Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a chart or graph showing the reduction in weekly drop seizure rate. The chart includes four different groups, labeled "Placebo," "Low," "Medium," and "High," with corresponding percentages and a numbered scale on the left side. There are also asterisks indicating statistical significance. However, without additional context or explanations of the abbreviations used, it is difficult to provide a more detailed description.*
The text represents a graph or chart showing the proportion of patients in different treatment groups and the reduction in weekly drop seizure frequency from baseline. The treatments evaluated are Placebo, Clobazam Low, Clobazam Medium, and Clobazam High. Without the visual elements of the chart, it is not possible to provide more details or insights.*
This is a partial description of some dental equipment. The text mentions "7 syringes" and an "adapter," suggesting that this is related to oral health or dental procedures. However, further context is needed to fully understand the purpose and function of this equipment.*
This appears to be a list of components for a medical instrument. The instrument is likely a syringe or similar device used for administering medication. The components mentioned are dosage indicators, a tip, a barrel, and a plunger.*
This is a description of a medication, Clobazam Oral Suspension, in a 120mL bottle with a National Drug Code (NDC) of 51672-4210-8. It is intended for oral administration only and comes with an enclosed medication guide and instructions for use. The bottle should be stored and dispensed in an upright position, and any remaining solution should be discarded within 50 days of opening. The product is a suspension and comes with two 10 mL syringes for administration. Additional information on dosage and administration can be found on the enclosed medication guide.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.